KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 158 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $131,000 | +4266.7% | 29,111 | +6080.7% | 0.01% | – |
| Q1 2022 | $3,000 | -62.5% | 471 | -62.6% | 0.00% | – |
| Q4 2021 | $8,000 | -87.3% | 1,258 | -88.3% | 0.00% | -100.0% |
| Q3 2021 | $63,000 | +2000.0% | 10,774 | +3503.3% | 0.00% | – |
| Q1 2021 | $3,000 | -85.0% | 299 | -78.3% | 0.00% | -100.0% |
| Q3 2020 | $20,000 | -67.2% | 1,379 | -57.1% | 0.00% | -71.4% |
| Q2 2020 | $61,000 | +190.5% | 3,213 | +194.5% | 0.01% | -22.2% |
| Q1 2020 | $21,000 | +950.0% | 1,091 | +305.6% | 0.01% | +800.0% |
| Q2 2019 | $2,000 | +100.0% | 269 | +232.1% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 81 | -22.9% | 0.00% | -100.0% |
| Q2 2018 | $2,000 | -33.3% | 105 | -68.6% | 0.00% | -50.0% |
| Q4 2017 | $3,000 | – | 334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |